医学
青光眼
眼压
开角型青光眼
视神经
无症状的
科克伦图书馆
眼科
疾病
病理生理学
重症监护医学
内科学
外科
随机对照试验
作者
Robert N. Weinreb,Tin Aung,Felipe A. Medeiros
出处
期刊:JAMA
[American Medical Association]
日期:2014-05-13
卷期号:311 (18): 1901-1901
被引量:3258
标识
DOI:10.1001/jama.2014.3192
摘要
Glaucoma is a worldwide leading cause of irreversible vision loss. Because it may be asymptomatic until a relatively late stage, diagnosis is frequently delayed. A general understanding of the disease pathophysiology, diagnosis, and treatment may assist primary care physicians in referring high-risk patients for comprehensive ophthalmologic examination and in more actively participating in the care of patients affected by this condition.To describe current evidence regarding the pathophysiology and treatment of open-angle glaucoma and angle-closure glaucoma.A literature search was conducted using MEDLINE, the Cochrane Library, and manuscript references for studies published in English between January 2000 and September 2013 on the topics open-angle glaucoma and angle-closure glaucoma. From the 4334 abstracts screened, 210 articles were selected that contained information on pathophysiology and treatment with relevance to primary care physicians.The glaucomas are a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and resulting changes in the optic nerve head. Loss of ganglion cells is related to the level of intraocular pressure, but other factors may also play a role. Reduction of intraocular pressure is the only proven method to treat the disease. Although treatment is usually initiated with ocular hypotensive drops, laser trabeculoplasty and surgery may also be used to slow disease progression.Primary care physicians can play an important role in the diagnosis of glaucoma by referring patients with positive family history or with suspicious optic nerve head findings for complete ophthalmologic examination. They can improve treatment outcomes by reinforcing the importance of medication adherence and persistence and by recognizing adverse reactions from glaucoma medications and surgeries.
科研通智能强力驱动
Strongly Powered by AbleSci AI